DrugPatentWatch Database Preview
Deutetrabenazine - Generic Drug Details
see a sample report or, see our see our flat-rate plans
What are the generic sources for deutetrabenazine and what is the scope of deutetrabenazine freedom to operate?
Deutetrabenazine
is the generic ingredient in one branded drug marketed by Teva Branded Pharm and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for deutetrabenazine
| US Patents: | 5 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 10 |
| Clinical Trials: | 6 |
| Patent Applications: | 8 |
| DailyMed Link: | deutetrabenazine at DailyMed |
Synonyms for deutetrabenazine
| (3R,11bR)-3-(2-methylpropyl)-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one |
| (3RS,11Brs)-9,10-di((2H3)methoxy)-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-benzo(a)quinolizin-2-one |
| [2H6]-(+)-Tetrabenazine|||[2H6]-(+)- 9,10-Dimethoxy-1,3R,4,6,7,11bR-hexahydro-3-isobutyl-2H-benzo[a]quinolizin-2-one |
| 1392826-25-3 |
| 2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-di(methoxy-d3)-3-(2-methylpropyl)-, (3R,11bR)-rel- |
| Austedo |
| CHEMBL3137326 |
| D10701 |
| DB12161 |
| Deutetrabenazine (USAN/INN) |
| Deutetrabenazine [USAN:INN] |
| Dutetrabenazine |
| GTPL8707 |
| HY-B0590S |
| Ro 1-9569 D6 |
| SCHEMBL13321841 |
| SCHEMBL16227993 |
| SCHEMBL16228022 |
| SD 809 |
| SD-809 |
| SD809 |
| Tetrabenazine D6 |
| UNII-P341G6W9NB component MKJIEFSOBYUXJB-VFJJUKLQSA-N |
| UNII-P341G6W9NB component MKJIEFSOBYUXJB-WEZHFFAMSA-N |
US Patents and Regulatory Information for deutetrabenazine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-002 | Apr 3, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-003 | Apr 3, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-002 | Apr 3, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-002 | Apr 3, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-003 | Apr 3, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-002 | Apr 3, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
International Patents for deutetrabenazine
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Denmark | 2326643 | ➤ Sign Up |
| India | 1662DEN2015 | ➤ Sign Up |
| Hong Kong | 1186728 | ➤ Sign Up |
| New Zealand | 591615 | ➤ Sign Up |
| Spain | 2563820 | ➤ Sign Up |
| Japan | 2016172782 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
